Knowledge, Experience, and Understanding

Mindful Capital Strategies

Practice Group Roll-Up Strategies

MCS has contracted with over 55 dental practices and structured roll-ups with aggregate valuations exceeding $100,000,000.

Dental

Practice Group Roll-Up Strategies

MCS has closed over $60,000,000 in Ophthalmology transactions while securing FDA, Health Canada, ISO, and MDSAP approvals.

Ophthalmology

Practice Group Roll-Up Strategies

MCS has developed a national comanaged
care plan in Canada, bringing optometrists
and ophthalmologists together.

Optometry

Practice Group Roll-Up Strategies

MCS is providing alternative roll up strategies in the medical spa sector, facilitating organic growth.

Medical Spa

Practice Group Roll-Up Strategies

MCS represents plastic surgery practices in both buy- and sell side capacities, creating exit strategies or expansion through M&A roll up opportunities.

Plastic Surgery

Practice Group Roll Up Strategies

MCS understands the broad range of buyers and intricacies of the dermatology sector.

Dermatology

Practice Group Roll-Up Strategies
Alternative M&A Strategies To Maximize Value
Our primary focus lies in targeted mergers and acquisitions (M&A), including integrated and non-integrated roll-ups, bolt-ons, tuck-ins, complex acquisitions, carve-outs, reverse mergers, and recapitalizations. Additionally, we provide corporate and business development services while identifying and establishing strategic partnerships that foster sustained corporate growth and pave the way for successful strategic exits.
Internal Consulting Transactions
Details available under NDA

MSO and Private Clinic

MSO PC

$54MM M&A Transaction

MCS MD

$100MM+ Dental Practice Sales

Dental Roll Ups
External Consulting Transactions
Details available under NDA

Medical Device: Ophthalmic

$54M merger including valuation, negotiations, and closing of the merger including support for FDA Pre Market Approval, clinical trials, and manufacturing scale-up with a new business model and corporate strategy for US and global market entry.

Dental: Roll Up

$105M ORAL SURGERY ROLL UP: Sourced, packaged, and represented as sell-side M&A advisors in a multi-state oral surgery practice roll up of 21 offices, 31 doctors in 3 states valued together at $105MM for majority sale with equity and earnouts financed by a PE fund.

Dental: Roll Up

$34M DENTAL ROLL UP: Sourced, packaged, and represented as sell-side M&A advisors for a multi-state general dentist practice roll up of 7 doctor owners in 3 states valued together at $34M for the US market entry of a Canadian DSO financed by a Toronto-based family office and a US-based healthcare private equity firm and credit facility.

Public Health: IDP

$32M MERGER AND LEVERAGED BUYOUT: Provided deal sourcing, valuation, synergy, negotiations, and post-transaction integration support in the merger of specialty infectious disease prevention and communications consulting firm as a public health carveout.

Medical Device: GI

$210MM STRATEGIC SALE: Identified and prequalified strategic investors for synergies, including selected strategic buyer, in the successful acquisition of the company while providing post-LOI diligence and revenue forecasting with business development and prototyping guidance for next-gen single-use GI devices and infection control treatments.

Medical Device: Diagnostics

$ 4.2M RAISE: Provided capital raise pitch, valuation, branding, prototyping, and market analysis guidance as part of a successful seed raise with well known Foundation and Innovation Center, followed by sourcing VC funding for a handheld, disposable biochemical device startup that provides accurate, quantitative evaluation of anemia in less than two minutes.

AI Fraud Detection

$ 7.2M RAISE: Provided capital raise pitch, valuation, market analysis and business development guidance in successful capital raise and 150% revenue growth with new clients via 2 years of foundation seed grants, followed by VC seed investment for this artificial intelligence-driven fraud detection and investigation startup that identifies and mitigates payments of fraudulent healthcare billing for private/government payors.

Aerospace: 3DP

$ 5.2M+ RAISE and JVs: Provided valuation, business model, marketing, and capital raise consulting for a ceramics, metal and biopolymer 3D printing (3DP) startup that provides custom design software and patented 3DP laser platforms to manufacture or prototype advanced aerospace engine and medical surgical parts/devices. MCS’ efforts secured joint ventures with a leading jet engine manufacturer and a large maintenance, repair and overhaul (MRO) company, as well as successful capital raises totaling $5.2M from a family office and undisclosed multi-million VC Series A investment.

Medical Device: Aesthetics

$250K STUDY FOR $205M CARVEOUT: As as buy-side M&A advisors, MCS partners delivered global market revenue, supply chain expense forecasts, and technical scouting of future merger targets with a leading innovation center. This informtaion was used for a Tier 1 global investment bank valuation opinion to be provided to a global PE group in a $205M leveraged buyout of a medical aesthetics company that manufactures laser devices for skin revitalization, body contouring, hair removal, and women’s health sold in over 130 countries.

Beverage: Spirits

$34MM REVERSE MERGER RAISE & NEW PRODUCT LAUNCH: We successfully brought several new distilled spirit brands to market including distillation, bottling, distribution, marketing, importation, distribution, and sales. The company successfully entered the public markets, achieving and holding a $30M+ market cap. Their two top spirits (vodka) achieved Gold Standard in World Spirits Competition.

Automotive: OEM

$30MM  MERGER CONSOLIDATION: Negotiated and managed the consolidation including all valuation, supply chain contracting, and corporate restructuring. We merged two Taiwanese OEM wheel manufacturers into a Chinese OEM wheel manufacturer headquartered in China resulting in a merged company. Results included combined annual revenue growth of 20% to over $100M USD with a 14% reduction in COGS and funds to open a new manufacturing facility.

Energy Storage: Li-Ion

$60MM STRATEGIC ACQUISITION: We implemented a corporate restructuring and acquisition/sale strategy to acquire majority ownership of a US and Germany-based lithium ion battery manufacturer through the acquisition of an Hague-based investment company that owned the required warrants, to be exercised post-acquisition for 56.2% ownership. Negotiated the relief of $20MM USD in debt and placed all assets and IP into an SPV, and restructured the company, which was sold to a large battery manufacturer in Bulgaria.

Services
MCS Provides Full Corporate Development

Corporate Strategies

MCS brings C-Suite and Board-level guidance to new heights that clarifies all aspects of your corporate strategy development and execution, ensuring direction and momentum as you grow, evolve or plan an exit.

Mergers & Acquisitions

MCS positions companies for successful M&A with capital introductions and negotiations at all stages for each transaction.

Capital Introductions and Value Based Diligence

We provide our clients with selective access to our exclusive MCS Investor Network of financing partners from commercial banks and private equity groups to family offices, venture capital groups, angel and high net-worth investors.

Corporate Restructuring and Market Readiness

If the timing of the M&A transaction is not quite right yet, MCS repositions companies for successful M&A via tried-and-true corporate restructuring and market readiness guidance.

Product Launch and Market Access

MCS’s executives have decades of marketing strategy and product launch experience in every sector in which we specialize.

Investor and Public Relations

Investor relations are at the core of obtaining support and attaining results; such an impact can propel a company’s profitability, growth, and market share, independent of the type of industry or the size of the enterprise.

Regulatory

We provide end-to-end regulatory affairs services that span the entire drug life cycle from early development through to submission and license approval to post-approval marketing maintenance. We support manufacturers, packagers, labelers, suppliers, distributors, importers, and warehouses.

Quality & Compliance

We provide GCP, GLP, and GMP consulting services for pharmaceuticals, natural health products, medical devices, cosmetics, and over-the-counter products.

Importing

The importation of regulated products into Canada requires prior approvals. We provide a clear path to product and establishment licenses while developing and maintaining your quality management system. License access includes drug products, OTC, natural health products (NHP), medical devices, active pharmaceutical ingredients (API), and cosmetics.

Social Hour
Connect with me on LinkedIn!
MCS Leadership
Don Schwall, Managing Partner

Don Schwall

Managing Partner

Nina Megateli-Das

Managing Partner

Biography Coming Soon

Schedule A Meeting

Company Zoom Request

If you would like to schedule a Zoom with our team to evaluate your transaction, please complete any of them fields below and we will follow up within 24 hours. *Asterisk denotes required field.

Mindful Capital Strategies (MCS) is a specialist consultancy firm focused on corporate restructuring and profitable M&A strategies across a varied portfolio of sectors and C-suite services.

We are not brokers or business brokers. We do not escrow clients funds, value stock or give legal or accounting advice.

Mindful Capital Strategies
Palm Beach, FL
United States of America
Monday - Friday 8:00 AM - 6:00 PM
info@mindfulcapitalstrategies.com
+1 561 819 8300